Cyclophosphamide

NDC 25021-249 · Sagent Pharmaceuticals

Generic nameCyclophosphamide

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)CYCLOPHOSPHAMIDE

Strength2 g/100mL

Marketing categoryANDA

Packages

25021-249-51 — 1 VIAL in 1 CARTON (25021-249-51) / 100 mL in 1 VIAL

J9075 — Injection, cyclophosphamide, not otherwise specified, 5 mg Medicare Part B payment limit (ASP + 6%): $0.57

FDA lists these products with the same active ingredient.

14335-470 — Cyclophosphamide for Injection, 14335-471 — Cyclophosphamide for Injection, 14335-472 — Cyclophosphamide for Injection, 14789-125 — Cyclophosphamide, 14789-126 — Cyclophosphamide, 16714-857 — cyclophosphamide, 16714-858 — cyclophosphamide, 16714-859 — cyclophosphamide, 25021-247 — Cyclophosphamide, 25021-248 — Cyclophosphamide, 39822-0250 — Cyclophosphamide, 39822-0255 — Cyclophosphamide, 39822-0260 — Cyclophosphamide, 42806-901 — cyclophosphamide, 42806-902 — cyclophosphamide, 42806-903 — cyclophosphamide, 46708-618 — Cyclophosphamide, 46708-619 — Cyclophosphamide, 55150-270 — Cyclophosphamide, 55150-271 — Cyclophosphamide, +62 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.